MAPT and dementia: The greater availability of neuropathological data among centenarians due to their high mortality rate is a potential opportunity for studies of other contributors to dementia because it allows for the evaluation of pathologies beyond what can be obtained from cerebrospinal fluid and imaging (e.g., beta-amyloid, tau, and vascular disease).